{
  "documentMetadata": {
    "title": "Herpes simplex, Oral lesions mouth, lips",
    "sourceFile": "Herpes simplex, Oral lesions_ mouth, lips.pdf",
    "lastUpdated": "2025-04-28"
  },
  "content": [
    {
      "type": "header",
      "level": 1,
      "text": "Clinical Setting"
    },
    {
      "type": "list",
      "items": [
        "Mucocutaneous Herpes simplex virus (HSV) infection, oral labial HSV infection.",
        "Gingivostomatitis / stomatitis: Visicular infection of the mouth (usually anterior) and lips.",
        "Fever blisters in normal host. Painful, more severe and often recurrent in immunocompromised host.",
        "Start treatment with prodrome symptoms (tingling/burning) before lesions appear."
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Etiologies"
    },
    {
      "type": "list",
      "items": [
        "Herpes simplex virus (HSV) (Types 1, 2)"
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Primary Regimens"
    },
    {
      "type": "list",
      "items": [
        "Oral regimens"
      ]
    },
    {
      "type": "drugRegimen",
      "regimenData": {
        "intent": "treatment",
        "components": [
          {
            "drug": "Valacyclovir",
            "dose": "2 gm",
            "route": "po",
            "frequency": "q12h x 1 day",
            "notes": "(see Comment for dosing reference)"
          },
          {
            "drug": "Acyclovir",
            "dose": "400 mg",
            "route": "po",
            "frequency": "tid x 5 days"
          },
          {
            "drug": "Famciclovir",
            "dose": "500 mg",
            "route": "po",
            "frequency": "bid x 7 days",
            "notes": "(FDA-approved for HIV patients only)"
          }
        ]
      }
    },
    {
      "type": "header",
      "level": 1,
      "text": "Alternative Regimens"
    },
    {
      "type": "list",
      "items": [
        "At first sign of prodrome: Famciclovir 1500 mg one dose or 750 mg q12h x 1 day (J Amer Acad Dermatol 55:47, 2006)",
        "Topical regimens (less preferred):"
      ]
    },
    {
      "type": "drugRegimen",
      "regimenData": {
        "intent": "treatment",
        "components": [
          {
            "drug": "Penciclovir",
            "dose": "1% cream",
            "route": "topical",
            "frequency": "q2h during day x 4 days"
          },
          {
            "drug": "Acyclovir",
            "dose": "5% cream",
            "route": "topical",
            "frequency": "6x/day (q3h) x 7 days",
            "notes": "(approved for HIV patients only)"
          }
        ]
      }
    },
    {
      "type": "header",
      "level": 1,
      "text": "Comments"
    },
    {
      "type": "list",
      "items": [
        "Valacyclovir more effective overall (Meta-analysis in J Oral Path Med 46:561, 2017)",
        "Symptoms reduction",
        "Oral regimens: Valacyclovir (1 day), Famciclovir (2 days), Acyclovir (1/2 day)",
        "Topical regimens: Penciclovir (1 day); Acyclovir (1/2 day)"
      ]
    }
  ]
}
